| dc.description.abstract | COVID-19 infected patients are diagnosed with “silent hypoxia” in absence of dyspnea.
Hypoxemia, is a life-threatening medical condition which drops the oxygen saturation
to 80% - 85% suddenly. However, due to hospital capacity limitations, the majority
of Covid-19 patients were treated at home. But regular monitoring of SpO2 level was
essential to diagnose silent hypoxia for immediate hospitalization and provide the medical
assistance. In this project work, a low-cost user-friendly Short Message Service (SMS)
base pulse oximeter to measure SpO2 level for early diagnosis of “Silent hypoxia” in
COVID-19 infected patients is implemented to minimize the risk. This novel remote
monitoring design of the SMS based-pulse oximeter is combined with a Global System
for Mobile Communications (GSM) module in order to send a SMS to the clinician about
the condition of the patient. Further, if the patient is diagnosed with “silent hypoxia”,
clinician will be informed automatically with a high-prioritized SMS. To validate the
performance of the new device, United States Food and Drug Administration (FDA)
approved pulse oximeter was used. According to the results, P > 0.05 which implies
that there is no significant difference and good correlation similarities exist between
them. This design contributes to reduce the mortality rate of Covid-19 patients and
critical conditions. Alternatively, the novel design improves the self-confidence of the
patients, hence the mental stability during the period of home-quarantine. This design
can be further improved to facilitate emerging technologies such as Hospital to Home
and Virtual Doctor in order to provide remote monitoring facilities to patients with other
conditions as well. | en_US |
